TITLE

CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHOEA (CDAD), ONSET IN THE COMMUNITY AND HOSPITAL

AUTHOR(S)
Johal, S.S.; Hammond, J.; Mahida, Y.R.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA92
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
CDAD is usually considered to be a problem that develops in patients following hospitalisation for another condition that requires administration of antibiotics. Little is known about patients that require admission to hospital following the onset of CDAD in the community. We have compared patients that developed CDAD following admission to hospital with those in whom the diarrhoea started in the community. Method: Patients admitted to hospital or developing diarrhoea as inpatients were studied. CDAD was diagnosed in the presence of diarrhoea (> 3 liquid motions in 24 h) and either positive stool C difficile cytotoxin test or pseudomembranes were seen at sigmoidoscopy and the diarrhoea responded to vancomycin or metronidazole. Results: Over a period of 30 months, 136 patients with CDAD (50 male and 86 female) of median age 82 year (range 24 - 97 year) were studied, of which 131 (96%) had taken broad spectrum antibiotic(s) prior to the onset of diarrhoea. In 38 (28%) diarrhoea developed in the community and in 98 (72%) diarrhoea developed while inpatient. Of the patients admitted with diarrhoea, 33 (86.8%) had been hospitalised over the preceding 12 months compared with 56 (57.1%) that developed diarrhoea as inpatient (p < 0.001). Prior to treatment, patients who developed diarrhoea in the community had a higher daily stool frequency (7.2 (±0.8) vs 4.6 (+0.2), p < 0.001) and shorter period of hospitalisation (23 (±3) vs 49 (±4) days, p < 0.001), but there was no difference in age, the duration of diarrhoea, CRP, or WBC. Of the patients who developed diarrhoea in the community, 21 (55.3%) were admitted from their own home with 23 (60.5%) returning there on discharge. Respective figures for patients that developed CDAD in hospital: 68 (69.4%) and 30 (30.6%, p < 0.001). Conclusions: Of hospitalised patients with CDAD, a significant proportion developed the disease in the community. A majority of these had been hospitalised over the preceding 12...
ACCESSION #
9747908

 

Related Articles

  • Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections. Mullane, Kathleen M.; Miller, Mark A.; Weiss, Karl; Lentnek, Arnold; Golan, Yoav; Sears, Pamela S.; Shue, Youe-Kong; Louie, Thomas J.; Gorbach, Sherwood L. // Clinical Infectious Diseases;9/1/2011, Vol. 53 Issue 5, p440 

    Background. Treatment guidelines recommend stopping all implicated antibiotics at the onset of Clostridium difficile infection (CDI), but many individuals have persistent or new infections necessitating the use of concomitant antibiotics (CAs). We used data from 2 phase 3 trials to study effects...

  • Markers of Intestinal Inflammation, Not Bacterial Burden, Correlate With Clinical Outcomes in Clostridium difficile Infection. El Feghaly, Rana E.; Stauber, Jennifer L.; Deych, Elena; Gonzalez, Carlos; Tarr, Phillip I.; Haslam, David B. // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1713 

    Fecal inflammatory markers at diagnosis correlate with diarrhea persistence and treatment failure in Clostridium difficile infection, whereas C. difficile fecal bacterial burden does not. C. difficile bacterial concentration decreases similarly in patients treated with metronidazole and...

  • Fidaxomicin inhibits toxin production in Clostridium difficile. Babakhani, Farah; Bouillaut, Laurent; Sears, Pamela; Sims, Carlee; Gomez, Abraham; Sonenshein, Abraham L. // Journal of Antimicrobial Chemotherapy (JAC);Mar2013, Vol. 68 Issue 3, p515 

    Objectives Fidaxomicin, which was recently approved for the treatment of Clostridium difficile-associated diarrhoea, demonstrates narrow-spectrum bactericidal activity via inhibition of RNA polymerase. In this study we evaluated its inhibitory activity versus C. difficile toxin gene expression...

  • Clostridium difficile in association with sporadic diarrhoea. Brettle, R.P.; Poxton, I.R.; Murdoch, J. McC.; Brown, R.; Byrne, Marie D.; Collee, J.G. // British Medical Journal (Clinical Research Edition);1/23/1982, Vol. 284 Issue 6311, p230 

    Investigates the association of Clostridium (Cl) difficile with sporadic diarrhea. Assessment of patients with severe or moderately severe gastrointestinal illness; Detection of Cl difficile cytotoxin in feces; Administration of vancomycin.

  • Safety Analysis of Fidaxomicin in Comparison With Oral Vancomycin for Clostridium difficile Infections. Weiss, Karl; Allgren, Robin L.; Sellers, Sarah // Clinical Infectious Diseases;Aug2012 Supplement 2, Vol. 55 Issue suppl_2, pS110 

    Fidaxomicin is a novel macrocyclic antibiotic recently approved by the US Food and Drug Administration for the treatment of Clostridium difficile–associated diarrhea in adults. We reviewed safety data from nonclinical studies and clinical trials (phases 1, 2A, and 3) with fidaxomicin. In...

  • Management of antibiotic related and Clostridium Difficile Colitis. Haboubi, Najib; Krivokapic, Zoran // Acta Chirurgica Iugoslavica;2014, Vol. 61 Issue 2, p65 

    Nearly all antibiotics can cause some form of diarrhoea. Clostridium difficile infection has become an important area in our daily clinical practice and is known to cause a broad spectrum of conditions ranging from asymptomatic carriage to the life-threatening pseudomembranous colitis (PMC),...

  • Isolation of Enterococcus raffinosus from an ostrich chick with diarrhoea. Salehi, Taghi; Badouei, Mahdi; Ghaffari, Mohammad; Khormali, Mahmood // Comparative Clinical Pathology;Apr2012, Vol. 21 Issue 2, p209 

    Enterococci have been incriminated as a cause of opportunistic infections in humans and different animal species. The glycopeptide-resistant Enterococcus raffinosus has been reported as an emerging pathogen in humans recently, but the importance of E. raffinosus in animals is largely unknown....

  • Antibiotic Associated Diarrhea in Children. ALAM, SEEMA; MUSHTAQ, MUDASIR // Indian Pediatrics;Jun2009, Vol. 46 Issue 6, p491 

    Context: Keeping in view the recent flooding of the Indian market with antibiotic and probiotic combinations, we decided to look at the prevalence of antibiotic associated diarrhea (AAD) and Clostridium difficile infection (CDI) in children and reviewed evidence available for use of probiotics...

  • DIARRHOEA. Watson, A.J.M. // BMJ: British Medical Journal (International Edition);5/16/92, Vol. 304 Issue 6837, p1302 

    Examines the incidence of diarrhea in Great Britain. Assessment on the common bacterial and protozoal causes of acute diarrhea; Symptoms and signs associated with chronic diarrhea; Indications for antibiotic treatment.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics